PTGX Jul 2024 40.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:48AM EDT. Market open.
| Previous Close | 1.1000 |
| Open | 1.0000 |
| Bid | 0.0500 |
| Ask | 1.0000 |
| Strike | 40.00 |
| Expire Date | 2024-07-19 |
| Day's Range | 0.9500 - 1.1000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 80 |
Simply Wall St.We Think Some Shareholders May Hesitate To Increase Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) CEO Compensation
Key Insights Protagonist Therapeutics to hold its Annual General Meeting on 20th of June Salary of US$655.2k is part of...
ACCESSWIREProtagonist Reports Updated Long Term Results from Rusfertide Phase 2 REVIVE Study at the EHA2024 Congress Showing Durable Hematocrit Control
Long term follow-up from REVIVE Phase 2 study up to 3 years shows durable hematocrit (Hct) control (< 45%), decreased phlebotomy use, long-term tolerability, and no new safety signals in patients with polycythemia vera Patients receiving rusfertide ...
- Simply Wall St.
Has Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Protagonist Therapeutics (NASDAQ:PTGX) has had a great run on the share market with its stock up by a significant 24...
© 2024 Yahoo. All rights reserved.